Dergiler / The Turkish Journal of Ear Nose and Throat / 2022 / Cilt: 32 - Sayı: 2

Evaluation of LRIG1 Expression in Larynx Pathologies

Sayfa
31–36
Yayın Tarihi
2022-10-19
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

However, LRIG1 was not correlated with overall survival of the LSCC.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Objective: Studies have been performed on many biomolecules to determine the prognosis of LSCC and predict the course of the disease.
📊
Temel Bulgular & Veri:Therefore, in this study, we aimed to investigate the expression levels of LRIG 1 in laryngeal cancer.Materials and Methods: In our study, 219 cases who underwent surgery due to LSCC and 88 randomly selected patients whose pathologic result were benign and premalignant lesions in Marmara University Pendik Education and Research Hospital between 2003 and 2018 were analyzed.
💡
Sonuç & Katkı:However, LRIG1 was not correlated with overall survival of the LSCC.
🔬Tür:Araştırma Makalesi
📍Kapsam:2003 Verileri
⚙️Değişkenler:LRIG1 · Laryngeal carcinoma · tumorigenesis

Abstract

Objective: Studies have been performed on many biomolecules to determine the prognosis of LSCC and predict the course of the disease. However, a molecular marker that can be used clinically has not yet been found. Therefore, in this study, we aimed to investigate the expression levels of LRIG 1 in laryngeal cancer.Materials and Methods: In our study, 219 cases who underwent surgery due to LSCC and 88 randomly selected patients whose pathologic result were benign and premalignant lesions in Marmara University Pendik Education and Research Hospital between 2003 and 2018 were analyzed. Patients’ data were obtained from the medical records. The tissue microarray method was used to evaluate specimens.Results: There was a statistically significant difference between the tumor differentiation, diagnosis, and the expression of LRIG1 (respectively p=0.045, p<0.001). Also, an increase in the degree of dysplasia in premalignant lesions correlates with a decrease in LRIG1 expression (p=0.015).Conclusion: Our findings suggest that LRIG1 plays a role in the early tumorigenesis of LSCC. Therefore, LRIG1 can be a target molecule for treatment approaches. However, LRIG1 was not correlated with overall survival of the LSCC.

🔖

Bu Makaleye Atıf Yap

GUNDOGDU, Y., Asya, O., Gönen, A., Muradov, T., Erçetin, S. Y., Cinel, Z. L., Yumuşakhuylu, A. C. (2022). Evaluation of LRIG1 Expression in Larynx Pathologies. The Turkish Journal of Ear Nose and Throat, Cilt: 32 - Sayı: 2, 31–36. https://ajindex.com/articles/597865

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (2)

  1. Howlader N, Noone A, Krapcho M, Miller D, Brest A, Yu M, et al. SEER Cancer Statistics Review, 1975-2018,
  2. National Cancer Institute. Bethesda, MD. 2018. https://seer.cancer.gov/statfacts/ html/laryn.html (Accession date: 25.04.2022 ) google scholar 2. Nocini R, Molteni G, Mattiuzzi C, Lippi G. Updates on larynx cancer epidemiology. Chin J Cancer Res 2020;32(1):18. google scholar 3. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021;71(3):209-49. google scholar 4. Pruess M, Fleischmann W, Kanapin A, Karavidopoulou Y, Kersey P, Kriventseva E, et al. The Proteome Analysis database: a tool for the in silico analysis of whole proteomes. Nucleic Acids Research 2003;31(1):414-7. google scholar 5. Kobe B, Kajava AV. The leucine-rich repeat as a protein recognition motif. Curr Opin Struct Biol 2001;11(6):725-32. google scholar 6. Nilsson J, Vallbo C, Guo D, Golovleva I, Hallberg B, Henriksson R, et al. Cloning, characterization, and expression of human LIG1. Biochem Biophys Res Commun 2001;284(5):1155-61. google scholar 7. Hedman Hk, Nilsson J, Guo D, Henriksson R. Is LRIG1 a tumour suppressor gene at chromosome 3p14.3? Acta Oncol 2002;41(4):352-4. google scholar 8. Jensen KB, Watt FM. Single-cell expression profiling of human epidermal stem and transit-amplifying cells: Lrig1 is a regulator of stem cell quiescence. PNAS 2006;103(32):11958-63. google scholar 9. Tanemura A, Nagasawa T, Inui S, Itami S. LRIG-1 provides a novel prognostic predictor in squamous cell carcinoma of the skin: immunohistochemical analysis for 38 cases. Dermatol Surg 2005;31(4):423-30. google scholar 10. Thomasson M, Wang B, Hammarsten P, Dahlman A, Persson JL, Josefsson A, et al. LRIG1 and the liar paradox in prostate cancer: a study of the expression and clinical significance of LRIG1 in prostate cancer. Int J Cancer 2011;128(12):2843-52. google scholar 11. Guo D, Nilsson J, Haapasalo H, Raheem O, Bergenheim T, Hedman H, et al. Perinuclear leucine-rich repeats and immunoglobulin-like domain proteins (LRIG1-3) as prognostic indicators in astrocytic tumors. Acta Neuropathol 2006;111(3):238-46. google scholar 12. Lindquist D, Kvarnbrink S, Henriksson R, Hedman H. LRIG and cancer prognosis. Acta Oncol 2014;53(9):1135-42. google scholar 13. Suzuki Y, Sato N, Tohyama M, Wanaka A, Takagi T. cDNA cloning of a novel membrane glycop